HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study.

Abstract
The main aim of this study was to compare the response to trivalent inactivated influenza vaccine in children who received a kidney transplant and were on steroid-free versus steroid-based immunosuppression. Groups: 1. Kidney transplant recipients on steroid-free immunosuppression (n=27); 2. Kidney transplant recipients on steroid-based immunosuppression (n=39); 3. Healthy controls (n=21). Hemagglutination inhibition titers against 2007-2008 A/H1N1 and A/H3N2 and B strains were measured before and 8 weeks postvaccination. Postvaccination geometric mean titers to A/H1N1 were significantly lower among both transplant groups than controls (p=0.025 and 0.015, respectively). Postvaccination titers to H3N2 and B strains were not statistically different between groups. Proportions of participants developing seroprotection were not different among groups. Both kidney transplant groups seroconverted less than controls for A/H1N1 (p=0.0002) and were no different from controls for B. For A/H3N2, the steroid-free group had the weakest seroconversion (p=0.008), possibly due to mycophenolate-enhanced exposure and a younger age. Overall, children after kidney transplantation demonstrated a good serologic response to the inactivated influenza vaccine although somewhat lower than controls. Steroid-free immunosuppression did not seem to present an advantage in antibody response. Data on inactivated influenza vaccine safety and efficacy was collected and demonstrated absence of acute rejection or laboratory-proven influenza for 6 months postvaccination.
AuthorsCorina Nailescu, Xiyan Xu, Hong Zhou, Henrietta Hall, Amy C Wilson, Jeffrey D Leiser, Deepa H Chand, Rudolph P Valentini, Diane Hebert, John D Mahan
JournalPediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 26 Issue 3 Pg. 459-67 (Mar 2011) ISSN: 1432-198X [Electronic] Germany
PMID21181206 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • Immunosuppressive Agents
  • Influenza Vaccines
  • Steroids
Topics
  • Acute Disease
  • Adolescent
  • Antibodies, Viral (blood)
  • Canada
  • Chi-Square Distribution
  • Child
  • Female
  • Graft Rejection (immunology, prevention & control)
  • Hemagglutination Inhibition Tests
  • Humans
  • Immunization Schedule
  • Immunosuppressive Agents (adverse effects, therapeutic use)
  • Influenza A Virus, H1N1 Subtype (immunology)
  • Influenza A Virus, H3N2 Subtype (immunology)
  • Influenza Vaccines (administration & dosage, adverse effects)
  • Influenza, Human (prevention & control, virology)
  • Kidney Transplantation (adverse effects)
  • Male
  • Steroids (adverse effects, therapeutic use)
  • Time Factors
  • Treatment Outcome
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: